Kiniksa Pharmaceuticals International, plc
KNSA· Nasdaq
KNSAKiniksa Pharmaceuticals International, plc
Quarterly figures for Kiniksa Pharmaceuticals International, plc, with source filings when available.
37 quarters. Jun 30, 2017 to Jun 30, 2026. USD.
Kiniksa Pharmaceuticals International, plc has filed its 10-Q within 25 to 29 days of period end across its last 8 quarters. The 10-K runs 55 to 71 days.
Kiniksa Pharmaceuticals International, plc · CIK 1730430 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 28, 2026 · pre-market | Jul 28, 2026 | 28 d | 10-Q | $243.60M | +55.4% | $0.30 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 28, 2026 · pre-market |
| Apr 28, 2026 |
| 28 d |
| 10-Q |
| $214.27M |
| +55.5% |
| $0.27 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 24, 2026 · pre-market | Feb 24, 2026 | 55 d | 10-K | $202.13M | +65.0% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 · pre-market | Oct 28, 2025 | 28 d | 10-Q | $180.86M | +61.2% | $0.23 | |
| Q2 2025 | Jun 30, 2025 | Jul 29, 2025 · pre-market | Jul 29, 2025 | 29 d | 10-Q | $156.80M | +44.3% | $0.23 | |
| Q1 2025 | Mar 31, 2025 | Apr 29, 2025 · pre-market | Apr 29, 2025 | 29 d | 10-Q | $137.79M | +72.5% | $0.11 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 25, 2025 · pre-market | Feb 25, 2025 | 56 d | 10-K | $122.54M | +46.9% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 29, 2024 · pre-market | Oct 29, 2024 | 29 d | 10-Q | $112.21M | +67.4% | -$0.18 | |
| Q2 2024 | Jun 30, 2024 | Jul 23, 2024 · pre-market | Jul 25, 2024 | 25 d | 10-Q | $108.63M | +52.0% | -$0.06 | |
| Q1 2024 | Mar 31, 2024 | Apr 23, 2024 · pre-market | Apr 25, 2024 | 25 d | 10-Q | $79.86M | +65.2% | -$0.25 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 28, 2024 · pre-market | Feb 28, 2024 | 59 d | 10-K | $83.40M | +34.8% | — | |
| Q3 2023 | Sep 30, 2023 | Oct 31, 2023 · pre-market | Nov 2, 2023 | 33 d | 10-Q | $67.05M | −32.4% | -$0.20 | |
| Q2 2023 | Jun 30, 2023 | Jul 25, 2023 · pre-market | Aug 1, 2023 | 32 d | 10-Q | $71.47M | +165.0% | $0.21 | |
| Q1 2023 | Mar 31, 2023 | May 2, 2023 · pre-market | May 4, 2023 | 34 d | 10-Q | $48.35M | +50.2% | -$0.18 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · pre-market | Mar 2, 2023 | 61 d | 10-K | $61.88M | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 1, 2022 · pre-market | Nov 3, 2022 | 34 d | 10-Q | $99.14M | +719.6% | $3.18 | |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 · pre-market | Aug 4, 2022 | 35 d | 10-Q | $26.97M | +250.1% | -$0.29 | |
| Q1 2022 | Mar 31, 2022 | May 3, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | $32.19M | — | -$0.36 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 22, 2022 · pre-market | Feb 24, 2022 | 55 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 1, 2021 · pre-market | Nov 4, 2021 | 35 d | 10-Q | $12.10M | — | -$0.44 | |
| Q2 2021 | Jun 30, 2021 | Aug 3, 2021 · pre-market | Aug 5, 2021 | 36 d | 10-Q | $7.70M | — | -$0.61 | |
| Q1 2021 | Mar 31, 2021 | May 4, 2021 · pre-market | May 6, 2021 | 36 d | 10-Q | — | — | -$0.72 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Feb 23, 2021 · pre-market | Feb 25, 2021 | 56 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · pre-market | Nov 5, 2020 | 36 d | 10-Q | — | — | -$0.66 | |
| Q2 2020 | Jun 30, 2020 | Jul 30, 2020 · pre-market | Aug 4, 2020 | 35 d | 10-Q | — | — | -$0.65 | |
| Q1 2020 | Mar 31, 2020 | Apr 28, 2020 · pre-market | May 4, 2020 | 34 d | 10-Q | — | — | -$0.48 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | Feb 26, 2020 · pre-market | Mar 5, 2020 | 65 d | 10-K | — | — | — | |
| Q3 2019 | Sep 30, 2019 | Oct 28, 2019 · after-hours | Nov 5, 2019 | 36 d | 10-Q | — | — | -$0.49 | |
| Q2 2019 | Jun 30, 2019 | Aug 12, 2019 · after-hours | Aug 13, 2019 | 44 d | 10-Q | — | — | -$0.68 | |
| Q1 2019 | Mar 31, 2019 | May 2, 2019 · pre-market | May 7, 2019 | 37 d | 10-Q | — | — | -$1.27 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | Mar 7, 2019 · pre-market | Mar 12, 2019 | 71 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | Nov 1, 2018 · pre-market | Nov 6, 2018 | 37 d | 10-Q | — | — | -$0.51 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 6, 2018 | 37 d | 10-Q | — | — | -$1.11 | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | — | — | -$6.45 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | — | — | — | — | — | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | — | — | -$8.25 | |
| Q2 2017 | Jun 30, 2017 | — | — | — | — | — | — | -$6.69 | |
